Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia

Clinical Case Reports

Numan Kutaiba²  Paul J. Gow¹  Janine French¹ 

[1] Liver Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia;Radiology, Austin Health, Melbourne, Victoria, Australia

关键词: Angiogenesis inhibitors;    blood flow velocity;    hepatic artery;    hereditary hemorrhagic telangiectasia;    magnetic resonance imaging;   

DOI  :  10.1002/ccr3.141

来源: Wiley

【 摘 要 】

Key Clinical Message

Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be further utilized in clinical settings and research.

【 授权许可】

CC BY-NC   
© 2014 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.